April 9, 2025
Immune checkpoint (IC) inhibitor drug holidays are safe in patients with metastatic melanoma who achieve an objective response (OR) during therapy, according to a study of […]
April 9, 2025
The US Food and Drug Administration (FDA) has approved nivolumab (Opdivo, Bristol Myers Squibb) with ipilimumab (Yervoy, Bristol Myers Squibb) for the treatment of adults and […]
April 9, 2025
ATHENS, Greece — Real-world data confirm that complete nodal dissection following a positive sentinel lymph node biopsy in patients with stage III melanoma and micrometastases does […]
April 9, 2025
ATHENS, Greece — According to the Global Cancer Observatory and the World Health Organization, over 300,000 new cases of invasive melanoma were diagnosed worldwide in 2022. […]
April 9, 2025
More effective combinations of targeted therapies, strategies to minimize side effects, the use of subcutaneous rather than intravenous immunotherapies, and artificial intelligence (AI) tools to better […]
April 7, 2025
A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for identifying recurrence risks in patients with early-stage melanoma who do not […]
April 7, 2025
TOPLINE: A new analysis found that the incidence of interval breast cancers diagnosed in screened patients has increased over an almost 30-year period, but the proportion […]
April 7, 2025
TOPLINE: The overall incidence of colorectal cancer (CRC) in the United Kingdom plateaued at 67.4 per 100,000 person-years from 2000 to 2021, with slight improvements observed […]
April 4, 2025
When Mateo Mejia Saldarriaga, MD, first started seeing multiple myeloma (MM) patients as a medical student in his native Colombia 10 years ago, he was intrigued […]